Brian Andrew Gordon

Brian Andrew Gordon

Auto-generated profile, based on publicly available information

Brian Andrew Gordon

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
DNDominantly Inherited Alzheimer Network
Dominantly Inherited Alzheimer Network
OPOliver Preische
Oliver Preische
SSStephanie A. Schultz
Stephanie A. Schultz
AAAnja Apel
Anja Apel
JKJens Kuhle
Jens Kuhle
MJMathias Jucker
Mathias Jucker

11 May 2016 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
MBMatthew R. Brier
Matthew R. Brier
BGBrian Gordon
Brian Gordon
KFKarl Friedrichsen
Karl Friedrichsen
JMJohn McCarthy
John McCarthy
ASAri Stern
Ari Stern
BABeau M. Ances
Beau M. Ances
PET imaging of pathological tau correlates more closely with Alzheimer’s disease–related cognitive impairment than does imaging of β-amyloid.

11 March 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TNThe Dominantly Inherited Alzheimer Network
The Dominantly Inherited Alzheimer Network
NBNicolas R. Barthélemy
Nicolas R. Barthélemy
YLYan Li
Yan Li
NJNelly Joseph-Mathurin
Nelly Joseph-Mathurin
BGBrian A. Gordon
Brian A. Gordon
EMEric McDade
Eric McDade

1 March 2018 in The Lancet Neurology
Verified
Journal Article
Closed access
BGBrian A Gordon
Brian A Gordon
TBTyler M Blazey
Tyler M Blazey
YSYi Su
Yi Su
AHAmrita Hari-Raj
Amrita Hari-Raj
ADAylin Dincer
Aylin Dincer
TBTammie L S Benzinger
Tammie L S Benzinger

21 February 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
NBNicolas R. Barthélemy
Nicolas R. Barthélemy
GSGemma Salvadó
Gemma Salvadó
SSSuzanne E. Schindler
Suzanne E. Schindler
YHYingxin He
Yingxin He
SJShorena Janelidze
Shorena Janelidze
OHOskar Hansson
Oskar Hansson
With the emergence of Alzheimer’s disease (AD) disease-modifying therapies, identifying patients who could benefit from these treatments becomes critical. In this study, we evaluated whether a precise blood test could perform as well as established cerebrospinal fluid (CSF) tests in detecting amyloid-β (Aβ) plaques and tau tangles. Plasma %p-tau217 (ratio of phosporylated-tau217 to non-phosphorylated tau) was analyzed by mass spectrometry in the Swedish BioFINDER-2 cohort (n = 1,422) and the US Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC) cohort (n = 337). Matched CSF samples were analyzed with clinically used and FDA-approved automated immunoassays for Aβ42/40 and p-tau181/Aβ42. The primary and secondary outcomes were detection of brain Aβ or tau pathology, respectively, using positron emission tomography (PET) imaging as the reference standard. Main analyses were focused on individuals with cognitive impairment (mild cognitive impairment and mild dementia), which is the target population for available disease-modifying treatments. Plasma %p-tau217 was clinically equivalent to FDA-approved CSF tests in classifying Aβ PET status, with an area under the curve (AUC) for both between 0.95 and 0.97. Plasma %p-tau217 was generally superior to CSF tests in classification of tau-PET with AUCs of 0.95–0.98. In cognitively impaired subcohorts (BioFINDER-2: n = 720; Knight ADRC: n = 50), plasma %p-tau217 had an accuracy, a positive predictive value and a negative predictive value of 89–90% for Aβ PET and 87–88% for tau PET status, which was clinically equivalent to CSF tests, further improving to 95% using a two-cutoffs approach. Blood plasma %p-tau217 demonstrated performance that was clinically equivalent or superior to clinically used FDA-approved CSF tests in the detection of AD pathology. Use of high-performance blood tests in clinical practice can improve access to accurate AD diagnosis and AD-specific treatments.

1 March 2018 in Neuron
Verified
Journal Article
Closed access
CSChihiro Sato
Chihiro Sato
NBNicolas R. Barthélemy
Nicolas R. Barthélemy
KMKwasi G. Mawuenyega
Kwasi G. Mawuenyega
BPBruce W. Patterson
Bruce W. Patterson
BGBrian A. Gordon
Brian A. Gordon
RBRandall J. Bateman
Randall J. Bateman